Advance your drug discovery pipeline today by leveraging the Molecular Devices portfolio of bioanalytical instruments, software, and reagents to investigate the major druggable target classes: GPCRs, kinases, ion channels, and transporters, as well as conduct pathway-based drug discovery.
With the broadest range of detection technologies across a variety of high-performance bioanalytical systems, industry-leading data acquisition and analysis as well as informatics software, and highly sensitive biological assays, we are the ideal choice to support your drug discovery efforts from target discovery through early safety assessment.
We offer a range of high-performance bioanalytical instruments, software, and assays to support the investigation of high-priority target classes as well as the discovery and validation of novel targets. Please select among the links below to learn more about how we can help drive your target discovery and validation programs.
Content: Our systems address all content needs from low to mid to high content analysis & screening.